Bristol-Myers Squibb Company (BMY) — Capital Reinvestment Ratio
Bristol-Myers Squibb Company (BMY) has a Capital Reinvestment Ratio of 0.31x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.10 Billion) in capital expenditures ($347.00 Million). See BMY net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bristol-Myers Squibb Company Capital Reinvestment Ratio (1989–2025)
This chart tracks Bristol-Myers Squibb Company's Capital Reinvestment Ratio across 37 annual periods. Check Bristol-Myers Squibb Company total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bristol-Myers Squibb Company (1989–2025)
Year-by-year Capital Reinvestment Ratio for Bristol-Myers Squibb Company from 1989 to 2025. For live market cap and broader valuation context, see market cap of Bristol-Myers Squibb Company.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | $14.16 Billion | $1.31 Billion | ▲ +12.7% |
| 2024 | 0.08x | $15.19 Billion | $1.25 Billion | ▼ -5.8% |
| 2023 | 0.09x | $13.86 Billion | $1.21 Billion | ▲ +1.9% |
| 2022 | 0.09x | $13.07 Billion | $1.12 Billion | ▲ +42.5% |
| 2021 | 0.06x | $16.21 Billion | $973.00 Million | ▲ +12.0% |
| 2020 | 0.05x | $14.05 Billion | $753.00 Million | ▼ -48.3% |
| 2019 | 0.10x | $8.07 Billion | $836.00 Million | ▼ -23.0% |
| 2018 | 0.13x | $7.07 Billion | $951.00 Million | ▼ -32.7% |
| 2017 | 0.20x | $5.28 Billion | $1.05 Billion | ▼ -49.7% |
| 2016 | 0.40x | $3.06 Billion | $1.22 Billion | ▲ +2.0% |
| 2015 | 0.39x | $2.10 Billion | $820.00 Million | ▲ +133.1% |
| 2014 | 0.17x | $3.15 Billion | $526.00 Million | ▲ +10.3% |
| 2013 | 0.15x | $3.54 Billion | $537.00 Million | ▲ +91.9% |
| 2012 | 0.08x | $6.94 Billion | $548.00 Million | ▲ +4.1% |
| 2011 | 0.08x | $4.84 Billion | $367.00 Million | ▼ -19.7% |
| 2010 | 0.09x | $4.49 Billion | $424.00 Million | ▼ -47.4% |
| 2009 | 0.18x | $4.07 Billion | $730.00 Million | ▼ -29.3% |
| 2008 | 0.25x | $3.71 Billion | $941.00 Million | ▼ -5.1% |
| 2007 | 0.27x | $3.15 Billion | $843.00 Million | ▼ -29.8% |
| 2006 | 0.38x | $2.08 Billion | $793.00 Million | ▼ -9.0% |
| 2005 | 0.42x | $1.84 Billion | $768.00 Million | ▲ +64.2% |
| 2004 | 0.25x | $3.18 Billion | $809.00 Million | ▼ -9.6% |
| 2003 | 0.28x | $3.51 Billion | $990.00 Million | ▼ -77.5% |
| 2002 | 1.25x | $945.00 Million | $1.18 Billion | ▲ +560.5% |
| 2001 | 0.19x | $5.40 Billion | $1.02 Billion | ▲ +49.6% |
| 2000 | 0.13x | $4.65 Billion | $589.00 Million | ▼ -24.6% |
| 1999 | 0.17x | $4.22 Billion | $709.00 Million | ▼ -19.4% |
| 1998 | 0.21x | $3.78 Billion | $788.00 Million | ▼ -32.7% |
| 1997 | 0.31x | $2.48 Billion | $767.00 Million | ▲ +36.1% |
| 1996 | 0.23x | $2.64 Billion | $601.00 Million | ▲ +10.9% |
| 1995 | 0.21x | $2.50 Billion | $513.00 Million | ▼ -17.6% |
| 1994 | 0.25x | $2.30 Billion | $573.00 Million | ▲ +12.7% |
| 1993 | 0.22x | $2.58 Billion | $570.00 Million | ▼ -30.8% |
| 1992 | 0.32x | $2.03 Billion | $647.00 Million | ▼ -6.8% |
| 1991 | 0.34x | $1.83 Billion | $628.00 Million | ▲ +16.9% |
| 1990 | 0.29x | $1.75 Billion | $513.00 Million | ▼ -37.2% |
| 1989 | 0.47x | $1.19 Billion | $555.00 Million | — |